Literature DB >> 25055961

Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures.

Jie Liu1, Hong Lu2, Yuan-Fu Lu1, Xiaohong Lei2, Julia Yue Cui3, Ewa Ellis4, Stephen C Strom5, Curtis D Klaassen6.   

Abstract

Bile acids (BAs) are known to regulate their own homeostasis, but the potency of individual bile acids is not known. This study examined the effects of cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA) and ursodeoxycholic acid (UDCA) on expression of BA synthesis and transport genes in human primary hepatocyte cultures. Hepatocytes were treated with the individual BAs at 10, 30, and 100μM for 48 h, and RNA was extracted for real-time PCR analysis. For the classic pathway of BA synthesis, BAs except for UDCA markedly suppressed CYP7A1 (70-95%), the rate-limiting enzyme of bile acid synthesis, but only moderately (35%) down-regulated CYP8B1 at a high concentration of 100μM. BAs had minimal effects on mRNA of two enzymes of the alternative pathway of BA synthesis, namely CYP27A1 and CYP7B1. BAs increased the two major target genes of the farnesoid X receptor (FXR), namely the small heterodimer partner (SHP) by fourfold, and markedly induced fibroblast growth factor 19 (FGF19) over 100-fold. The BA uptake transporter Na(+)-taurocholate co-transporting polypeptide was unaffected, whereas the efflux transporter bile salt export pump was increased 15-fold and OSTα/β were increased 10-100-fold by BAs. The expression of the organic anion transporting polypeptide 1B3 (OATP1B3; sixfold), ATP-binding cassette (ABC) transporter G5 (ABCG5; sixfold), multidrug associated protein-2 (MRP2; twofold), and MRP3 (threefold) were also increased, albeit to lesser degrees. In general, CDCA was the most potent and effective BA in regulating these genes important for BA homeostasis, whereas DCA and CA were intermediate, LCA the least, and UDCA ineffective.
© The Author 2014. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  BSEP; CYP7A1; FGF19; Human primary hepatocyte cultures; OSTα/β; bile acids

Mesh:

Substances:

Year:  2014        PMID: 25055961      PMCID: PMC4271050          DOI: 10.1093/toxsci/kfu151

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  44 in total

1.  The use of human hepatocytes to investigate bile acid synthesis.

Authors:  Ewa C S Ellis; Lisa-Mari Nilsson
Journal:  Methods Mol Biol       Date:  2010

2.  Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice.

Authors:  Youcai Zhang; Curtis D Klaassen
Journal:  J Lipid Res       Date:  2010-07-29       Impact factor: 5.922

3.  Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes.

Authors:  Tracy L Marion; Cassandra H Perry; Robert L St Claire; Kim L R Brouwer
Journal:  Toxicol Appl Pharmacol       Date:  2012-02-11       Impact factor: 4.219

4.  Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.

Authors:  Eiichiro Ogimura; Shuichi Sekine; Toshiharu Horie
Journal:  Biochem Biophys Res Commun       Date:  2011-11-15       Impact factor: 3.575

5.  Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice.

Authors:  Peizhen Song; Youcai Zhang; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2011-07-11       Impact factor: 4.849

6.  Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.

Authors:  Tiangang Li; Michelle Matozel; Shannon Boehme; Bo Kong; Lisa-Mari Nilsson; Grace Guo; Ewa Ellis; John Y L Chiang
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

7.  Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice.

Authors:  Bo Kong; Li Wang; John Y L Chiang; Youcai Zhang; Curtis D Klaassen; Grace L Guo
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

Review 8.  The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation.

Authors:  Thijs W H Pols; Lilia G Noriega; Mitsunori Nomura; Johan Auwerx; Kristina Schoonjans
Journal:  J Hepatol       Date:  2010-12-09       Impact factor: 25.083

9.  Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.

Authors:  Iván L Csanaky; Hong Lu; Youcai Zhang; Kenichiro Ogura; Supratim Choudhuri; Curtis D Klaassen
Journal:  Hepatology       Date:  2010-10-14       Impact factor: 17.425

10.  A novel bile acid-activated vitamin D receptor signaling in human hepatocytes.

Authors:  Shuxin Han; Tiangang Li; Ewa Ellis; Stephen Strom; John Y L Chiang
Journal:  Mol Endocrinol       Date:  2010-04-06
View more
  35 in total

1.  No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.

Authors:  Gustavo Villalona; Amber Price; Keith Blomenkamp; Chandrashekhara Manithody; Saurabh Saxena; Thomas Ratchford; Matthew Westrich; Vindhya Kakarla; Shruthika Pochampally; William Phillips; Nicole Heafner; Niraja Korremla; Jose Greenspon; Miguel A Guzman; Ajay Kumar Jain
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-04-27       Impact factor: 4.016

2.  Berberine-induced Inactivation of Signal Transducer and Activator of Transcription 5 Signaling Promotes Male-specific Expression of a Bile Acid Uptake Transporter.

Authors:  Pengli Bu; Yuan Le; Yue Zhang; Youcai Zhang; Xingguo Cheng
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

3.  Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.

Authors:  Andrea Mignarri; Alessandro Magni; Marina Del Puppo; Gian Nicola Gallus; Ingemar Björkhem; Antonio Federico; Maria Teresa Dotti
Journal:  J Inherit Metab Dis       Date:  2015-07-08       Impact factor: 4.982

Review 4.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

Review 5.  Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.

Authors:  Maciej J Zamek-Gliszczynski; Mitchell E Taub; Paresh P Chothe; Xiaoyan Chu; Kathleen M Giacomini; Richard B Kim; Adrian S Ray; Sophie L Stocker; Jashvant D Unadkat; Matthias B Wittwer; Cindy Xia; Sook-Wah Yee; Lei Zhang; Yan Zhang
Journal:  Clin Pharmacol Ther       Date:  2018-08-08       Impact factor: 6.875

6.  Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.

Authors:  Melina M Malinen; Izna Ali; Jacqueline Bezençon; James J Beaudoin; Kim L R Brouwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-02-08       Impact factor: 4.052

Review 7.  Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery.

Authors:  Matthew G Browning; Bernardo M Pessoa; Jad Khoraki; Guilherme M Campos
Journal:  Curr Obes Rep       Date:  2019-06

Review 8.  ABCG5 and ABCG8: more than a defense against xenosterols.

Authors:  Shailendra B Patel; Gregory A Graf; Ryan E Temel
Journal:  J Lipid Res       Date:  2018-05-04       Impact factor: 5.922

9.  Novel in Vitro Method Reveals Drugs That Inhibit Organic Solute Transporter Alpha/Beta (OSTα/β).

Authors:  Melina M Malinen; Antti Kauttonen; James J Beaudoin; Noora Sjöstedt; Paavo Honkakoski; Kim L R Brouwer
Journal:  Mol Pharm       Date:  2018-12-14       Impact factor: 4.939

Review 10.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.